Benjamin Edwards Inc’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-75
Closed -$5K 735
2024
Q1
$5K Sell
75
-34
-31% -$2.15K ﹤0.01% 670
2023
Q4
$8K Sell
109
-579
-84% -$38K ﹤0.01% 592
2023
Q3
$47K Sell
688
-32
-4% -$2.71K 0.01% 460
2023
Q2
$68K Sell
720
-283
-28% -$22.1K 0.02% 435
2023
Q1
$68K Sell
1,003
-345
-26% -$22.2K 0.02% 421
2022
Q4
$67K Buy
1,348
+166
+14% +$6.78K 0.02% 394
2022
Q3
$38K Buy
1,182
+4
+0.3% +$165 0.01% 439
2022
Q2
$46K Buy
1,178
+20
+2% +$1.07K 0.01% 435
2022
Q1
$81K Buy
1,158
+12
+1% +$877 0.02% 396
2021
Q4
$89K Buy
1,146
+632
+123% +$55.8K 0.03% 358
2021
Q3
$49K Buy
514
+47
+10% +$4.96K 0.03% 304
2021
Q2
$58K Buy
467
+108
+30% +$12.9K 0.04% 257
2021
Q1
$47K Buy
359
+54
+18% +$7.39K 0.04% 256
2020
Q4
$40K Buy
+305
New +$36.9K 0.03% 261

Other funds holding EXAS

Benjamin Edwards Inc's EXAS Position: Q2 2024 in Review

Benjamin Edwards Inc sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 75 shares — an estimated $5K sold.

Benjamin Edwards Inc first reported a position in EXAS in Q4 2020 and held it in 14 quarters. The position peaked at $89K in Q4 2021. 542 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Benjamin Edwards Inc reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Benjamin Edwards Inc sold 75 Exact Sciences shares in Q2 2024, an estimated $5K.
  • Benjamin Edwards Inc first reported a position in Exact Sciences in Q4 2020 and held it in 14 quarters.
  • Benjamin Edwards Inc's Exact Sciences position peaked at $89K in Q4 2021.
  • 542 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Benjamin Edwards Inc's 13F filing for Q2 2024, filed 12 Aug 2024.